{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:21:01Z","timestamp":1791566461010,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024YFFK0349"],"award-info":[{"award-number":["2024YFFK0349"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M752245"],"award-info":[{"award-number":["2024M752245"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024HXBH084"],"award-info":[{"award-number":["2024HXBH084"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2406604"],"award-info":[{"award-number":["2022YFC2406604"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2406600"],"award-info":[{"award-number":["2022YFC2406600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.intimp.2025.115769","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:22:53Z","timestamp":1761960173000},"page":"115769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P1","title":["Tryptophan metabolism alteration is associated with rapidly progressive interstitial lung disease of anti-MDA5+ dermatomyositis"],"prefix":"10.1016","volume":"168","author":[{"given":"Hongjiang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixue","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changpei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyi","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qibing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.intimp.2025.115769_bb0005","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s12016-020-08822-5","article-title":"Interstitial lung disease in anti-MDA5 positive dermatomyositis","volume":"60","author":"Wu","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"10.1016\/j.intimp.2025.115769_bb0010","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1684\/ejd.2019.3634","article-title":"Clinical features and poor prognostic factors of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with rapid progressive interstitial lung disease","volume":"29","author":"Motegi","year":"2019","journal-title":"Eur. J. Dermatol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115769_bb0015","doi-asserted-by":"crossref","first-page":"274","DOI":"10.55563\/clinexprheumatol\/di1083","article-title":"Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies","volume":"40","author":"Cavagna","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"issue":"4","key":"10.1016\/j.intimp.2025.115769_bb0020","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/art.42308","article-title":"Identification of three different phenotypes in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis patients: implications for prediction of rapidly progressive interstitial lung disease","volume":"75","author":"Xu","year":"2023","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115769_bb0025","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1212\/WNL.0000000000009727","article-title":"Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: study of 121 cases","volume":"95","author":"Allenbach","year":"2020","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.intimp.2025.115769_bb0030","doi-asserted-by":"crossref","first-page":"304","DOI":"10.55563\/clinexprheumatol\/df2oc3","article-title":"Anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis exhibit three clinical phenotypes with different prognoses","volume":"40","author":"Yang","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115769_bb0035","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41584-023-01054-9","article-title":"Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progress","volume":"20","author":"Lu","year":"2024","journal-title":"Nat. Rev. Rheumatol."},{"issue":"4","key":"10.1016\/j.intimp.2025.115769_bb0040","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.semarthrit.2020.05.008","article-title":"The altered metabolism profile in pathogenesis of idiopathic inflammatory myopathies","volume":"50","author":"Liu","year":"2020","journal-title":"Semin. Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.intimp.2025.115769_bb0045","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1002\/jcsm.13045","article-title":"Integrated analysis of plasma and urine reveals unique metabolomic profiles in idiopathic inflammatory myopathies subtypes","volume":"13","author":"Liu","year":"2022","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.intimp.2025.115769_bb0050","doi-asserted-by":"crossref","first-page":"1188257","DOI":"10.3389\/fimmu.2023.1188257","article-title":"Serum metabolomic analysis reveals disorder of steroid hormone biosynthesis in patients with idiopathic inflammatory myopathy","volume":"14","author":"Huo","year":"2023","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2025.115769_bb0055","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1007\/s10238-023-01073-6","article-title":"Metabolic profiling of patients with different idiopathic inflammatory myopathy subtypes reveals potential biomarkers in plasma","volume":"23","author":"Zhao","year":"2023","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.intimp.2025.115769_bb0060","doi-asserted-by":"crossref","first-page":"1429010","DOI":"10.3389\/fimmu.2024.1429010","article-title":"Altered metabolic profiles of dermatomyositis with different myositis-specific autoantibodies associated with clinical phenotype","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2025.115769_bb0065","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrm.2016.25","article-title":"Metabolomics: beyond biomarkers and towards mechanisms","volume":"17","author":"Johnson","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"10","key":"10.1016\/j.intimp.2025.115769_bb0070","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1007\/s10067-022-06263-3","article-title":"Enhanced tryptophan-kynurenine metabolism via indoleamine 2,3-dioxygenase 1 induction in dermatomyositis","volume":"41","author":"Wu","year":"2022","journal-title":"Clin. Rheumatol."},{"issue":"12","key":"10.1016\/j.intimp.2025.115769_bb0075","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European league against rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2025.115769_bb0080","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13075-016-1033-y","article-title":"Effects on muscle tissue remodeling and lipid metabolism in muscle tissue from adult patients with polymyositis or dermatomyositis treated with immunosuppressive agents","volume":"18","author":"Loell","year":"2016","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2025.115769_bb0085","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13075-018-1579-y","article-title":"Targeted lipidomics analysis identified altered serum lipid profiles in patients with polymyositis and dermatomyositis","volume":"20","author":"Raouf","year":"2018","journal-title":"Arthritis Res. Ther."},{"issue":"5","key":"10.1016\/j.intimp.2025.115769_bb0090","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11306-019-1539-9","article-title":"Metabolomic profiling for identification of potential biomarkers in patients with dermatomyositis","volume":"15","author":"Zhang","year":"2019","journal-title":"Metabolomics"},{"issue":"8","key":"10.1016\/j.intimp.2025.115769_bb0095","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.cmet.2023.06.004","article-title":"Tryptophan metabolism in health and disease","volume":"35","author":"Xue","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.intimp.2025.115769_bb0100","doi-asserted-by":"crossref","first-page":"1257159","DOI":"10.3389\/fimmu.2023.1257159","article-title":"A systematic review and meta-analysis of the kynurenine pathway of tryptophan metabolism in rheumatic diseases","volume":"14","author":"Mangoni","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115769_bb0105","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/ard.21.1.63","article-title":"Metabolism of tryptophan in rheumatoid arthritis","volume":"21","author":"Bett","year":"1962","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.intimp.2025.115769_bb0110","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/ard.21.4.388","article-title":"Effect of pyridoxine on tryptophan metabolism in rheumatoid arthritis","volume":"21","author":"Bett","year":"1962","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.intimp.2025.115769_bb0115","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.3899\/jrheum.141505","article-title":"Downregulation of tryptophan-related metabolomic profile in rheumatoid arthritis synovial fluid","volume":"42","author":"Kang","year":"2015","journal-title":"J. Rheumatol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115769_bb0120","first-page":"450","article-title":"Tryptophan metabolism in rheumatoid arthritis is associated with rheumatoid factor and predicts joint pathology evaluated by the rheumatoid arthritis MRI score (RAMRIS)","volume":"37","author":"Pongratz","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"issue":"3","key":"10.1016\/j.intimp.2025.115769_bb0125","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/ard-2023-224014","article-title":"Counteracting tryptophan metabolism alterations as a new therapeutic strategy for rheumatoid arthritis","volume":"83","author":"Moulin","year":"2024","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.intimp.2025.115769_bb0130","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2249.2007.03480.x","article-title":"Indoleamine 2,3-dioxygenase activity is increased in patients with systemic lupus erythematosus and predicts disease activation in the sunny season","volume":"150","author":"Pertovaara","year":"2007","journal-title":"Clin. Exp. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2025.115769_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125109","article-title":"Type I interferon-mediated skewing of the serotonin synthesis is associated with severe disease in systemic lupus erythematosus","volume":"10","author":"Lood","year":"2015","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.intimp.2025.115769_bb0140","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2017-000254","article-title":"Kynurenine pathway is altered in patients with SLE and associated with severe fatigue","volume":"5","author":"Akesson","year":"2018","journal-title":"Lupus Sci Med."},{"issue":"12","key":"10.1016\/j.intimp.2025.115769_bb0145","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s00726-023-03353-7","article-title":"Altered kynurenine pathway metabolism and association with disease activity in patients with systemic lupus","volume":"55","author":"Eryavuz Onmaz","year":"2023","journal-title":"Amino Acids"},{"issue":"7","key":"10.1016\/j.intimp.2025.115769_bb0150","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/art.39629","article-title":"Association of Increased Treg Cell Levels with Elevated Indoleamine 2,3-dioxygenase activity and an imbalanced kynurenine pathway in interferon-positive primary Sjogren\u2019s syndrome","volume":"68","author":"Maria","year":"2016","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115769_bb0155","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12931-023-02653-6","article-title":"Identification of kynurenine and quinolinic acid as promising serum biomarkers for drug-induced interstitial lung diseases","volume":"25","author":"Sun","year":"2024","journal-title":"Respir. Res."},{"issue":"29","key":"10.1016\/j.intimp.2025.115769_bb0160","doi-asserted-by":"crossref","first-page":"E5881","DOI":"10.1073\/pnas.1615280114","article-title":"Inhibition of acute lethal pulmonary inflammation by the IDO-AhR pathway","volume":"114","author":"Lee","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"145","key":"10.1016\/j.intimp.2025.115769_bb0165","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0009-2017","article-title":"The role of macrophages in interstitial lung diseases: Number 3 in the Series \u201cPathology for the clinician\u201d Edited by Peter Dorfmuller and Alberto Cavazza","volume":"26","author":"Rossi","year":"2017","journal-title":"Eur Respir Rev."},{"key":"10.1016\/j.intimp.2025.115769_bb0170","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cytogfr.2020.11.003","article-title":"Macrophage-derived cytokines in pneumonia: linking cellular immunology and genetics","volume":"59","author":"Dukhinova","year":"2021","journal-title":"Cytokine Growth Factor Rev."},{"issue":"16","key":"10.1016\/j.intimp.2025.115769_bb0175","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2313070121","article-title":"Autoimmunity against melanoma differentiation-associated gene 5 induces interstitial lung disease mimicking dermatomyositis in mice","volume":"121","author":"Ichimura","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.intimp.2025.115769_bb0180","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/rheumatology\/keac229","article-title":"Evaluation and validation of the prognostic value of anti-MDA5 IgG subclasses in dermatomyositis-associated interstitial lung disease","volume":"62","author":"Xu","year":"2022","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.intimp.2025.115769_bb0185","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1186\/s13023-025-03921-y","article-title":"Anti-MDA5 antibody IgG1 subtype is associated with rapidly progressive interstitial lung disease in anti-MDA5-positive dermatomyositis","volume":"20","author":"Wu","year":"2025","journal-title":"Orphanet J. Rare Dis."},{"issue":"10","key":"10.1016\/j.intimp.2025.115769_bb0190","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1093\/rheumatology\/kead063","article-title":"High prevalence and mortality of pneumocystis jirovecii pneumonia in anti-MDA5 antibody-positive dermatomyositis","volume":"62","author":"Chen","year":"2023","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.intimp.2025.115769_bb0195","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1093\/rheumatology\/kead034","article-title":"Compounded sulfamethoxazole improved the prognosis of dermatomyositis patients positive with anti-melanoma differentiation-associated gene 5","volume":"62","author":"Liu","year":"2023","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.intimp.2025.115769_bb0200","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/cmi.2017.143","article-title":"IDO1 in cancer: a Gemini of immune checkpoints","volume":"15","author":"Zhai","year":"2018","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115769_bb0205","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nrd3793","article-title":"Kynurenines in the CNS: recent advances and new questions","volume":"12","author":"Vecsei","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.intimp.2025.115769_bb0210","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/schbul\/sbw221","article-title":"Kynurenic acid in schizophrenia: a systematic review and Meta-analysis","volume":"43","author":"Plitman","year":"2017","journal-title":"Schizophr. Bull."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925017576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925017576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T19:40:53Z","timestamp":1781898053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925017576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":42,"alternative-id":["S1567576925017576"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115769","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tryptophan metabolism alteration is associated with rapidly progressive interstitial lung disease of anti-MDA5+ dermatomyositis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115769","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115769"}}